Clomipramine and neuroleptic malignant syndrome Patient Reports February 12, 2012

Clomipramine Side Effects Report #5030739-9
Clomipramine side effect was reported by a Physician from UNITED KINGDOM on June 09, 2006. Male patient, 57 years of age, was diagnosed with dementia  and was treated with Clomipramine. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Clomipramine dosage: 20 MG, DAILY, UNK. During the same period patient was treated with CLOMIPRAMINE HYDROCHLORIDE, PROMAZINE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Clomipramine Side Effects Report #4718382-X
Clomipramine side effect was reported by a Consumer or non-health professional from JAPAN on July 13, 2005. Male patient, 55 years of age, was treated with Clomipramine. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Clomipramine dosage: unknown. During the same period patient was treated with MAPROTILINE HYDROCHLORIDE, AMITRIPTYLINE, MEXILETINE. Patient was hospitalized. Patient recovered.

Clomipramine Side Effects Report #4729356-7
Clomipramine side effect was reported by a Consumer or non-health professional from JAPAN on July 13, 2005. Male patient, 55 years of age, was treated with Clomipramine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, musculoskeletal stiffness, neuroleptic malignant syndrome, pyrexia. Clomipramine dosage: unknown. During the same period patient was treated with MAPROTILINE HYDROCHLORIDE, AMITRIPTYLINE, MEXILETINE. Patient was hospitalized. Patient recovered.

Clomipramine Side Effects Report #4855662-1
Clomipramine side effect was reported by a Consumer or non-health professional from JAPAN on July 13, 2005. Male patient, 55 years of age, was treated with Clomipramine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, injury, musculoskeletal stiffness, neuroleptic malignant syndrome, pyrexia. Clomipramine dosage: unknown. During the same period patient was treated with MAPROTILINE HYDROCHLORIDE, AMITRIPTYLINE, MEXILETINE. Patient was hospitalized. Patient recovered.